Be the first to like this
This presentation throws light on:
• What is outcomes-, risk-, or value-based contracting?
• What is driving this?
• How does it benefit pharma, payers, patients?
• What metrics are critical to develop then monitor these contracts?
• How can pharma prove the safety, efficacy, and cost effectiveness of its products, demonstrating the impact and outcomes needed to meet contractual obligations?
For more information on our Life Sciences solutions, please